Ezubere SARS-CoV-2 Antigen Rapid Test (Colloidal Gold) maka nnwale onwe onye bụ maka nchọpụta qualitative nke SARS-CoV-2 Antigen (protein Nucleocapsid) na nlele mmiri mmadụ na vitro.
1. igwe mmadụ nyocha, dị ka ụlọ ọgwụ, ọdụ ụgbọ elu, ọdụ, obodo, wdg.
2. obere oge na-aga n'ihu onyunyo.
* Ntụle imi imi n'ihu, adịghị emerụ ahụ
* Dị mfe iji
* Ọ dị mma, enweghị akụrụngwa achọrọ
* Ngwa ngwa, nsonaazụ n'ime nkeji 15-20
* Ọnụ-arụ ọrụ nke ọma
Ihe mejupụtara nje virus SARS-CoV-2 bụ akụkụ ise: yinye mkpụrụ ndụ RNA na protein anọ. Ihe oyi akwa kacha elu nke urughuru bụ Spike Protein (S), na envelopu nke dị n'okpuru Spike bụ Envelopu Protein (E) na Protein Membrane (M). Isi ihe dị n'ime envelopu ahụ bụ usoro apịaji apịaji nke nwere agbụ RNA na protein Nucleocapsid (N). N'iji ụkpụrụ nke njikọta nke antigen na mgbochi, ọnụnọ nke SARS-CoV-2 antigen (protein Nucleocapsid) nwere ike ịchọpụta site na mgbochi.
Uru dị na Elisa na PCR
Usoro | Ọnụ ego nke ELISA | RT-PCR | Ngwa nyocha ọla edo nke colloidal (ọlaedo colloidal) |
Ọnụ ngwá ọrụ | Dị oke ọnụ | Dị oke ọnụ | Dị ọnụ ala |
Oge nchọpụta | Ogologo oge | Ogologo oge | Nkenke |
Mmụba Nkọwapụta |
Dị ike | Dị ike | Dị ike |
gburugburu ebe obibi Ihe achọrọ |
Elu | Elu | Dị ala |
Ọrụ Ihe isi ike |
Elu | Elu | Dị ala |
Emebere arụmọrụ SARS-CoV-2 Antigen Rapid Test (Colloidal Gold) site na ụdị 859 anakọtara n'aka ndị ọrịa nwere mgbaàmà nke a na-enyo enyo na ha nwere COVID-19. A na-anakọta ma nwalee ụdị swab imi dị n'ihu dịka ihe achọrọ nke ntuziaka maka ojiji. Nchekwa, njem na nchọpụta nke ihe nlele mgbe nchịkọta gasịrị zutere ihe ndị dị mkpa nke ntuziaka maka ojiji. N'otu oge ahụ, ahụrụ SARS-CoV-2 site na reagent nchọpụta nucleic acid mberede.
Nchịkọta arụmọrụ ụlọ ọgwụ nke WIZ'S SARS-CoV-2 Antigen Rapid Test (Colloidal Gold)
Nsonaazụ ule | Nsonaazụ PCR ntụaka | ||
Nke dị mma | Ihe ọjọọ | Mkpokọta | |
Nke dị mma | 328 | 0 | 328 |
Ihe ọjọọ | 14 | 517 | 531 |
Mkpokọta | 342 | 517 | 859 |
PPA: 95.91% (C.I. 93.25% ~ 97.55%)
NPA: 100.00% (C.I. 99.26% ~ 100.00%)
OPA: 98.37% (C.I. 97.28% ~ 99.03%)
Anyị, ndị nrụpụta, na nke a, na-ekwupụta na ngwaahịa (s) dị ka akọwapụtara n'elu na-ezute (s) nke dabara adaba nke European Directive 98/79/EC na in vitro Diagnostic Medical Devices. Akwụkwọ niile na-akwado teknụzụ na-egosi nnabata bụ ndị nrụpụta na-edobe ma ndị nnọchite anya ikike na Europe nwere ike mee ya.
Mba. | Aha ngwaahịa | Ụdị | Nkọwapụta (T/Kit) |
CE Asambodo |
1 | Nnwale ngwa ngwa SARS-CoV-2 Antigen | nasopharyngeal/oropharyngeal nchịkọta ihe atụ swab |
1/2/5/10/20/25 | EE |
2 | Nyocha SARS-CoV-2 Antigen | nasopharyngeal/oropharyngeal nchịkọta ihe atụ swab |
1/2/5/10/20/25 | EE |
3 | Nnwale ngwa ngwa nke SARS-CoV-2 (saliva) | Saliva | 1/2/5/10/20/25 | EE |
4 | Nnwale ngwa ngwa SARS-CoV-2 Antigen (Colloidal Gold) | mkpokọta swab imi | 1/2/5/10/20/25 | EE |
5 | Nnwale ngwa ngwa SARS-CoV-2 Antigen (Sputum/Saliva/Stool) | Ụgbụgbọ/Asọ/Nsa | 1/2/5/10/20/25 | EE |
Ụzọ mbupu | Usoro mbupu | Mpaghara |
Express | TNT /FEDEX /DHL/ UPS | Mba niile |
Oke osimiri | FOB/CIF/CFR/DDU | Mba niile |
Ụgbọ okporo ígwè | DDP | Mba Europe |
Oke osimiri + Express | DDP | Mba Europe /USA/Canada/Australia/Southeast Asia/Middle East |
A: Both.We have been in this field for more than 7years.With elu àgwà ngwaahịa na asọmpi price, anyị ji ezi obi na-atụ anya ịzụlite ibe-aba uru azụmahịa na anyị ahịa n'ụwa nile.
A: T/T,L/C,D/A,D/P na ndị ọzọ.
A: EXW, FOB, CFR, CIF, DDU na ndị ọzọ.
A: Dị ka ọ na-adịkarị, ọ ga-ewe 15 ruo 30 ụbọchị mgbe ị nwetasịrị nkwụnye ego Oge nnyefe a kapịrị ọnụ na-adabere na ihe ndị ahụ na ọnụ ọgụgụ nke iwu gị.
A: Ee, anyị nwere ike ịmepụta site na nlele gị ma ọ bụ eserese teknụzụ.
A: Ọ bụrụ na ọnụ ọgụgụ ahụ dị ntakịrị, ihe nlele ahụ ga-abụ n'efu, mana ndị ahịa ga-akwụ ụgwọ ụgwọ akwụkwọ ozi.
A: Ee, anyị nwere 100% ule tupu nnyefe.
A: Anyị na-edebe ezigbo mma na ọnụahịa asọmpi iji hụ na ndị ahịa anyị na-erite uru; na anyị na-asọpụrụ onye ọ bụla ahịa dị ka enyi anyị na anyị ji ezi obi na-azụ ahịa na-eme enyi na ha.